COVID‐19 in a patient with severe asthma treated with Omalizumab

Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

(2020) Jin-jin Zhang et al.   ALLERGY

The Evolving Algorithm of Biological Selection in Severe Asthma

(2020) Nikolaos G. Papadopoulos et al.   ALLERGY

COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids

(2020) Michael C Peters et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

(2020) Wei-jie Guan et al.   EUROPEAN RESPIRATORY JOURNAL

Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2

(2020) Daniel J. Jackson et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

(2020) Annemarie B Docherty et al.   BMJ-British Medical Journal

Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab

(2018) Michelle A. Gill et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations

(2015) Stephen J. Teach et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY